PL1820509T3 - Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania - Google Patents

Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania

Info

Publication number
PL1820509T3
PL1820509T3 PL07380021T PL07380021T PL1820509T3 PL 1820509 T3 PL1820509 T3 PL 1820509T3 PL 07380021 T PL07380021 T PL 07380021T PL 07380021 T PL07380021 T PL 07380021T PL 1820509 T3 PL1820509 T3 PL 1820509T3
Authority
PL
Poland
Prior art keywords
therapeutic preparation
fvlla
high purity
obtaining same
preparation
Prior art date
Application number
PL07380021T
Other languages
English (en)
Inventor
Gamon Salvador Grancha
Debart Pere Ristol
Nieto Juan Ignacio Jorquera
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36676691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1820509(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of PL1820509T3 publication Critical patent/PL1820509T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL07380021T 2006-02-17 2007-02-05 Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania PL1820509T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200600373A ES2257225B1 (es) 2006-02-17 2006-02-17 Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion.
EP07380021A EP1820509B1 (en) 2006-02-17 2007-02-05 Therapeutic preparation of very high purity FVlla and method for obtaining same

Publications (1)

Publication Number Publication Date
PL1820509T3 true PL1820509T3 (pl) 2009-12-31

Family

ID=36676691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07380021T PL1820509T3 (pl) 2006-02-17 2007-02-05 Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania

Country Status (8)

Country Link
US (1) US7531513B2 (pl)
EP (1) EP1820509B1 (pl)
JP (1) JP5196799B2 (pl)
AT (1) ATE435657T1 (pl)
DE (1) DE602007001467D1 (pl)
ES (2) ES2257225B1 (pl)
PL (1) PL1820509T3 (pl)
PT (1) PT1820509E (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5698659B2 (ja) * 2008-05-30 2015-04-08 ノボ ノルディスク ヘルス ケア アーゲー ポリペプチド修飾反応を制御する方法
EP2471542B1 (en) * 2009-08-28 2016-04-27 Osaka Air Machine Service, Ltd. Therapeutic agent for liver-related diseases
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
EP3995141B1 (en) 2016-04-28 2024-01-03 Alkahest, Inc. Plasma fractions as therapy for thymic cancer
LT3484502T (lt) 2016-08-18 2021-12-10 Alkahest, Inc. Kraujo plazmos frakcijos, kaip su senėjimu susijusio pažinimo sutrikimo gydymo priemonė
MX2019012795A (es) 2017-04-26 2020-02-13 Alkahest Inc Régimen de dosificación para el tratamiento de deterioros cognitivos y motores con plasma de sangre y productos de plasma de sangre.
SG11202100347QA (en) 2018-07-20 2021-02-25 Alkahest Inc Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
SG11202103696XA (en) 2018-10-26 2021-05-28 Alkahest Inc Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery
AU2020378245A1 (en) 2019-11-04 2022-04-07 Alkahest, Inc. Blood plasma fractions for use in muscle regeneration
CN114746100B (zh) 2019-11-20 2024-10-25 万能溶剂有限公司 用于肝再生的血浆级分
EP4689665A1 (en) 2023-03-29 2026-02-11 Grifols Worldwide Operations Limited Compositions and methods of preparation of blood plasma products with reduced levels of fceriss autoantibodies
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4470969A (en) * 1983-12-02 1984-09-11 Miles Laboratories, Inc. Process for producing a concentrate of coagulation factors VII and VIIa
FR2632524B1 (fr) * 1988-06-09 1992-03-13 Fondation Nale Transfusion San Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
FR2684999A1 (fr) * 1991-12-16 1993-06-18 Aquitaine Dev Transf Sanguine Procede de fabrication d'un concentre de facteur vii active de haute purete essentiellement depourvu des facteurs vitamine k dependants et des facteurs viiic et viiicag.
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US6310183B1 (en) * 1997-09-10 2001-10-30 Novo Nordisk A/S Coagulation factor VIIa composition
JP2000103800A (ja) * 1998-09-29 2000-04-11 Yoshitomi Pharmaceut Ind Ltd 免疫グロブリンａの精製方法
EP1280548B1 (en) * 2000-05-03 2013-12-11 Novo Nordisk Health Care AG Subcutaneous administration of coagulation factor VII
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
CN1671410B (zh) * 2002-06-21 2010-05-12 诺和诺德医疗保健公司 因子ⅶ多肽的稳定化固体组合物
JP2007522805A (ja) * 2004-02-03 2007-08-16 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 新規化合物
US20070037966A1 (en) * 2004-05-04 2007-02-15 Novo Nordisk A/S Hydrophobic interaction chromatography purification of factor VII polypeptides
RU2411959C2 (ru) * 2004-06-29 2011-02-20 Релайанс Лайф Сайенсиз Пвт Лтд Способ получения безопасных в вирусном отношении биологических текучих сред

Also Published As

Publication number Publication date
ES2327013T3 (es) 2009-10-22
US20070197440A1 (en) 2007-08-23
JP2007217415A (ja) 2007-08-30
PT1820509E (pt) 2009-09-02
ES2257225A1 (es) 2006-07-16
EP1820509A1 (en) 2007-08-22
EP1820509B1 (en) 2009-07-08
US7531513B2 (en) 2009-05-12
JP5196799B2 (ja) 2013-05-15
DE602007001467D1 (de) 2009-08-20
ES2257225B1 (es) 2007-03-16
ATE435657T1 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
PL1820509T3 (pl) Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania
WO2004083361A3 (en) FVII OR FVIIa VARIANTS
EP2279244A4 (en) METHOD AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
NZ594814A (en) Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
NZ623123A (en) A process for concentration of a polypeptide
TW200514790A (en) Bispecific antibody substituting for functional protein
TW200806317A (en) Methods for reducing protein aggregation
EP1350842A3 (de) Rekombinante terminale Deoxynukleotidyltransferase mit verbesserter Funktionalität
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
NZ598176A (en) Disintegrin variants and pharmaceutical uses thereof
SG163600A1 (en) Methods for the treatment of muscle loss
WO2005117977A8 (en) Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
NZ598056A (en) Blood coagulation protein conjugates
NO20072661L (no) Rensing av glykopeptider
EP2039367A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
WO2006100679A3 (en) Recombinant antibodies against human type ii transglutaminase and uses thereof
SE0401631D0 (sv) New Composition
DE502007002251D1 (de) Oligopeptide enthaltende dermatologische Zusammensetzungen zur Steigerung der Hautempfindlichkeit
NO20072579L (no) Modifisert kakaoprodukt og fremgangsmate for fremstilling derav
WO2005086825A3 (en) Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion